Telcon RF Pharmaceutical Inc banner
T

Telcon RF Pharmaceutical Inc
KOSDAQ:200230

Watchlist Manager
Telcon RF Pharmaceutical Inc
KOSDAQ:200230
Watchlist
Price: 628 KRW -1.26% Market Closed
Market Cap: ₩43B

Telcon RF Pharmaceutical Inc
Net Issuance of Common Stock

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Telcon RF Pharmaceutical Inc
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
T
Telcon RF Pharmaceutical Inc
KOSDAQ:200230
Net Issuance of Common Stock
₩40.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
DreamTech Co Ltd
KRX:192650
Net Issuance of Common Stock
-₩9.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
KH Electron Co Ltd
KOSDAQ:111870
Net Issuance of Common Stock
₩11B
CAGR 3-Years
23%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
P
Pavonine Co Ltd
KOSDAQ:177830
Net Issuance of Common Stock
-₩2.2B
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
PJ Electronics Co Ltd
KOSDAQ:006140
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Telcon RF Pharmaceutical Inc
Glance View

TELCON RF PHARMACEUTICAL.Inc. engages in the manufacture, development and sale of cable assemblies and medicinal products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2014-11-24. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.

Intrinsic Value
1 524.67 KRW
Undervaluation 59%
Intrinsic Value
Price ₩628
T

See Also

What is Telcon RF Pharmaceutical Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
40.3B KRW

Based on the financial report for Sep 30, 2025, Telcon RF Pharmaceutical Inc's Net Issuance of Common Stock amounts to 40.3B KRW.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett